Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Geriatr Psychol Neuropsychiatr Vieil ; 18(1): 88-96, 2020 03 01.
Artigo em Francês | MEDLINE | ID: mdl-32160989

RESUMO

Depression in the elderly is common, and associated with major functional impact, impaired quality of life and significant risk of suicide. Often undetected, it may also be insufficiently treated when diagnosed. Few therapeutic trials have specifically addressed depression in the elderly and guidelines for screening and management are most often based on expert opinion or extrapolation of data from younger patients. The objective of this article is to provide a synthesis of current knowledge on depression in the elderly and to recall, on the one hand, the importance of a targeted screening, and, on the other hand, the importance of a personalized management resulting from a global and multidisciplinary assessment.


Assuntos
Antidepressivos/uso terapêutico , Depressão/diagnóstico , Depressão/tratamento farmacológico , Idoso , Humanos , Psicoterapia , Qualidade de Vida
2.
Geriatr Psychol Neuropsychiatr Vieil ; 16(3): 229-240, 2018 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-30063025

RESUMO

Atrial fibrillation is the most frequent rhythm disorder in elderly patients. Moreover, the risk of stroke and the bleeding risk under anticoagulant treatment are the highest in this population. Vitamin K antagonists were until now the reference treatment of the anticoagulant treatment and they demonstrated a net benefit, including in elderly patients. The availability of the new oral anticoagulants, which do not require biological monitoring, simplified the anticoagulant treatment. However, data for the use of these molecules in elderly population remain limited. The benefit-risk ratio must not be assessed for this therapeutic class taken as a whole but for each molecule and according to the patient profile.


Assuntos
Anticoagulantes/uso terapêutico , Fibrilação Atrial/tratamento farmacológico , Avaliação Geriátrica , Idoso , Idoso de 80 Anos ou mais , Humanos , Medicina de Precisão
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA